Can an internal nasal lesion represent a telangiectasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, an internal nasal lesion can absolutely be a telangiectasia

Telangiectasias are among the most common vascular lesions found within the nasal cavity and represent a well-established cause of nasal bleeding, both in patients with hereditary hemorrhagic telangiectasia (HHT) and in those without any systemic disease.

Telangiectasias in HHT

In patients with HHT, nasal telangiectasias are the hallmark finding and occur in approximately 90% of adults 1. These lesions are located on the nasal mucosa and are the primary cause of recurrent epistaxis in this population, which affects over 90% of HHT patients 1.

Distribution and Morphology

The distribution of nasal telangiectasias in HHT patients shows specific patterns:

  • Predilection sites: Primarily in the anterior nasal cavity, particularly the anterior nasal septum 2
  • Other common locations: Middle turbinates, nasal floor, valve area, and can extend to posterior nasal cavity and nasopharynx 2
  • Morphologic variations: Telangiectasias appear as spots, loops, spiders, or clustered "raspberry-like" formations 2
  • Size variations: Range from punctate lesions to large prominent vessels 3

The morphology and distribution correlate with bleeding severity - larger, more prominent telangiectasias correlate with higher frequency of epistaxis, and greater number of involved nasal subsites correlates with higher intensity of nosebleeds 3.

Clinical Grading

A validated grading system categorizes nasal telangiectasias into three grades 4:

  • Mild: Few punctate lesions
  • Moderate: Multiple telangiectasias/large arteriovenous malformations involving anterior nasal septum
  • Severe: Diffuse involvement of nasal mucosa with telangiectasias

This grading correlates significantly with epistaxis severity and quality of life (r = 0.8, p = 0.006) 4.

Isolated Primary Telangiectasias (Non-HHT)

Critically, telangiectasias can occur as isolated primary lesions in patients without HHT or any systemic disease 5. This is an important clinical entity that has been documented but may be underrecognized.

Key Features of Isolated Nasal Telangiectasias

In a case series of 16 patients with epistaxis from isolated telangiectasias (not associated with HHT) 5:

  • Location distribution: Anterior septum (42%), nasal sidewall (16%), inferior meatus (10%), posterior septum (10%), nasal floor (10%), middle turbinate (5%), inferior turbinate (5%)
  • Clinical significance: 6 of 16 cases (38%) presented with intractable epistaxis
  • Treatment response: Successfully controlled with bipolar electrosurgery 5

Common Pitfall

Do not assume all nasal telangiectasias indicate HHT. While telangiectasias are diagnostic clues for HHT, they are not specific to this condition 6. Isolated primary telangiectasias represent a previously underreported but clinically significant source of nasal bleeding that can be managed effectively once identified endoscopically 5.

Diagnostic Approach

When encountering an internal nasal lesion that appears to be a telangiectasia:

  1. Perform nasal endoscopy with rigid endoscopes to document morphology, size, and distribution 2
  2. Assess for HHT using Curaçao criteria if multiple telangiectasias or recurrent epistaxis present 7
  3. Look for extranasal telangiectasias: Oral cavity, facial skin, hands, auricles, thorax (in descending order of frequency in HHT) 6
  4. Document bleeding history: Frequency, duration, intensity, and need for transfusions 3

Age consideration: Cutaneous telangiectasias in HHT can appear as early as 6 years of age, earlier than traditionally thought 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.